Synergy between Phage Sb-1 and Oxacillin against Methicillin-Resistant

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

1. Bacteriophage therapy and antimicrobial resistance: a scoping review using the "One Health" framework.Infection · 2026
   Review
2. Phage Intolerance Impacts Antibiotic Susceptibility and Virulence in Staphylococcus aureus.Current microbiology · 2026
   Article
3. Broth Optical Density-Based Assessment for Phage Therapy: Turbidity Reduction, Antibacterial Virulence, and Time-Kill.Viruses · 2026
   Review
4. Staphylococcal phages as agents of evolution and innovation: From gene flow to next-generation therapeutics.Genetics and molecular biology · 2026
   Article
5. A comprehensive review of emerging therapeutic strategies against methicillin-resistantFrontiers in microbiology · 2026
   Review
6. Broad-spectrum phage cocktail targetingFrontiers in microbiology · 2026
   Article
7. Bacterial meningitis in adults: therapeutic challenges in the era of antibiotic resistance and the potential of bacteriophages and associated by products.Frontiers in cellular and infection microbiology · 2026
   Review
8. Enhanced antibacterial properties of amoxicillin-loaded silver nanoparticles against Methicillin-resistantPeerJ · 2026
   Article
9. Optimizing phage-antibiotic combinations: impact of administration order against daptomycin non-susceptible (DNS) MRSA clinical isolates.Antimicrobial agents and chemotherapy · 2025
   Article
10. Pharmacological evaluation of phage-antibiotic synergism against clinical isolates of multi-drug resistant Staphylococcus aureus in a burn-induced infection mouse model.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
11. Journal of clinical microbiology · 2025
    Article
12. Combined Forces Against Bacteria: Phages and Antibiotics.Health science reports · 2025
    Article
13. A TAT Peptide-Functionalized Liposome Delivery Phage System (TAT-Lip@PHM) for an Enhanced Eradication of Intracellular MRSA.Pharmaceutics · 2025
    Article
14. [Phage therapy in Germany-Update 2025].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025
    Review
15. Re-Emergence of Bacteriophages and Their Products as Antibacterial Agents: An Overview.International journal of molecular sciences · 2025
    Review
16. Antibiotic Resistance ofPharmaceuticals (Basel, Switzerland) · 2025
    Review
17. Isolation, characterization, and potential application of Acinetobacter baumannii phages against extensively drug-resistant strains.Virus genes · 2024
    Article
18. Viruses · 2024
    Review
19. Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny.mBio · 2024
    Article
20. An effective antibiofilm strategy based on bacteriophages armed with silver nanoparticles.Scientific reports · 2024
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as